Ontology highlight
ABSTRACT:
INSTRUMENT(S): Q Exactive HF
ORGANISM(S): Streptomyces Rimosus Subsp. Rimosus
SUBMITTER: Christian Rückert-Reed
LAB HEAD: Jörn Kalinowski
PROVIDER: PXD042182 | Pride | 2024-01-26
REPOSITORIES: Pride
Action | DRS | |||
---|---|---|---|---|
2021-04-14_CR_P1.raw | Raw | |||
2021-04-14_CR_P2.raw | Raw | |||
2021-04-14_CR_P3.raw | Raw | |||
2021-04-14_CR_P4.raw | Raw | |||
2021-04-14_CR_P5.raw | Raw |
Items per page: 5 1 - 5 of 13 |
Beganovic Selma S Rückert-Reed Christian C Sucipto Hilda H Shu Wei W Gläser Lars L Patschkowski Thomas T Struck Ben B Kalinowski Jörn J Luzhetskyy Andriy A Wittmann Christoph C
Microbial cell factories 20231028 1
<h4>Background</h4>Oxytetracycline which is derived from Streptomyces rimosus, inhibits a wide range of bacteria and is industrially important. The underlying biosynthetic processes are complex and hinder rational engineering, so industrial manufacturing currently relies on classical mutants for production. While the biochemistry underlying oxytetracycline synthesis is known to involve polyketide synthase, hyperproducing strains of S. rimosus have not been extensively studied, limiting our knowl ...[more]